Total Payments
$10,169
2024 Payments
$504.61
Companies
41
Transactions
295
Medicare Patients
1,210
Medicare Billing
$82,320
Payment Breakdown by Category
Food & Beverage$9,963 (98.0%)
Education$205.50 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,963 | 289 | 98.0% |
| Education | $205.50 | 6 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,458 | 51 | $0 (2024) |
| Lilly USA, LLC | $782.22 | 40 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $696.45 | 17 | $0 (2021) |
| PFIZER INC. | $691.20 | 34 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $641.77 | 22 | $0 (2022) |
| Astellas Pharma US Inc | $630.69 | 30 | $0 (2024) |
| Allergan Inc. | $458.07 | 11 | $0 (2019) |
| ABBVIE INC. | $450.96 | 5 | $0 (2024) |
| Novo Nordisk Inc | $388.62 | 16 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $362.51 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $504.61 | 7 | ABBVIE INC. ($240.04) |
| 2023 | $716.90 | 17 | E.R. Squibb & Sons, L.L.C. ($164.53) |
| 2022 | $656.16 | 11 | Ferring Pharmaceuticals Inc. ($104.74) |
| 2021 | $794.64 | 27 | AstraZeneca Pharmaceuticals LP ($176.63) |
| 2020 | $814.12 | 38 | AstraZeneca Pharmaceuticals LP ($324.89) |
| 2019 | $1,957 | 53 | Janssen Pharmaceuticals, Inc ($237.12) |
| 2018 | $1,819 | 71 | AstraZeneca Pharmaceuticals LP ($408.15) |
| 2017 | $2,906 | 71 | Boehringer Ingelheim Pharmaceuticals, Inc. ($409.63) |
All Payment Transactions
295 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $154.61 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 09/25/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/14/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Biological | ||||||
| 03/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $54.17 | General |
| Category: Respiratory | ||||||
| 02/02/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: VACCINES | ||||||
| 01/30/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $115.03 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/26/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: NEUROLOGY | ||||||
| 09/19/2023 | AbbVie Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $115.03 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/05/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: NEUROLOGY | ||||||
| 08/29/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $82.78 | General |
| Category: Cardiovascular | ||||||
| 08/23/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Biological | ||||||
| 05/06/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: INSOMNIA | ||||||
| 04/26/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $50.93 | General |
| Category: Cardiovascular | ||||||
| 04/04/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $76.91 | General |
| Category: Diabetes | ||||||
| 03/01/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $116.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/22/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $16.42 | General |
| 02/03/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Oncology | ||||||
| 02/01/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $85.00 | General |
| 01/30/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.40 | General |
| Category: Cardiovascular | ||||||
| 01/24/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: ETONOGESTREL | ||||||
| 01/16/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Urology | ||||||
| 01/09/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Cardio-renal | ||||||
| 12/14/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 240 | 302 | $41,219 | $11,722 |
| 2022 | 4 | 120 | 160 | $29,142 | $8,199 |
| 2021 | 10 | 378 | 598 | $105,290 | $29,206 |
| 2020 | 14 | 472 | 723 | $124,097 | $33,192 |
Total Patients
1,210
Total Services
1,783
Medicare Billing
$82,320
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 100 | 148 | $28,416 | $7,142 | 25.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 23 | 23 | $6,877 | $2,891 | 42.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 22 | $2,508 | $729.19 | 29.1% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 25 | 25 | $1,175 | $447.25 | 38.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 19 | 19 | $893.00 | $339.91 | 38.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 34 | 44 | $1,056 | $141.24 | 13.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 19 | 21 | $294.00 | $31.86 | 10.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 94 | $18,048 | $4,900 | 27.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 28 | $5,432 | $1,706 | 31.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 14 | 19 | $3,496 | $1,014 | 29.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 19 | $2,166 | $580.09 | 26.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 117 | 169 | $32,448 | $9,442 | 29.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 47 | 150 | $19,350 | $4,425 | 22.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 21 | 23 | $12,535 | $3,367 | 26.9% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 27 | 55 | $10,120 | $2,922 | 28.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 20 | 20 | $5,980 | $2,618 | 43.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 60 | 67 | $7,638 | $2,347 | 30.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 26 | 30 | $7,620 | $1,560 | 20.5% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2021 | 20 | 39 | $4,641 | $1,278 | 27.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 16 | $4,528 | $1,162 | 25.7% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 25 | 29 | $430.00 | $84.87 | 19.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 40 | 43 | $23,435 | $6,981 | 29.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 63 | 220 | $28,380 | $6,918 | 24.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 111 | 144 | $27,648 | $6,713 | 24.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 33 | 56 | $10,304 | $2,784 | 27.0% |
About Dr. Mark Stevens, MD
Dr. Mark Stevens, MD is a Family Medicine healthcare provider based in Victoria, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1427033786.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Stevens, MD has received a total of $10,169 in payments from pharmaceutical and medical device companies, with $504.61 received in 2024. These payments were reported across 295 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($9,963).
As a Medicare-enrolled provider, Stevens has provided services to 1,210 Medicare beneficiaries, totaling 1,783 services with total Medicare billing of $82,320. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Victoria, TX
- Active Since 12/09/2005
- Last Updated 08/26/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427033786
Products in Payments
- FARXIGA (Drug) $1,094
- AVYCAZ (Drug) $738.95
- XARELTO (Drug) $564.01
- JARDIANCE (Drug) $514.23
- ELIQUIS (Drug) $401.49
- ENTRESTO (Drug) $285.30
- EUCRISA (Drug) $260.10
- TRULICITY (Drug) $241.97
- BYDUREON (Drug) $239.09
- ORBACTIV (Drug) $224.38
- Ozempic (Drug) $211.25
- NUZYRA (Drug) $191.36
- Tymlos (Biological) $188.57
- PRADAXA (Drug) $187.69
- FORTEO (Drug) $172.49
- MYRBETRIQ (Drug) $171.60
- Repatha (Biological) $169.66
- KYPHON Balloon Kyphoplasty (Device) $165.46
- TOUJEO (Drug) $164.76
- XERAVA (Drug) $154.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Victoria
Dr. Angela Klawitter, M.d, M.D
Family Medicine — Payments: $14,146
Family Medicine $14,146
Veronica Guel-Valdivia, Md, MD
Family Medicine — Payments: $13,651
Family Medicine $13,651
Eliezer Castaneda, M.d, M.D
Family Medicine — Payments: $11,906
Family Medicine $11,906
Ms. Kathleen Steiner, Md, MD
Family Medicine — Payments: $8,095
Family Medicine $8,095
Braden Coleman, Md, MD
Family Medicine — Payments: $6,162
Family Medicine $6,162
Grant Henry, Md, MD
Family Medicine — Payments: $4,993
Family Medicine $4,993